dbt Core
dbt Fusion's second beta is adapter work: ClickHouse gets materializations, indexes, and catalogs
A side-by-side editorial comparison of Fulcrum and pharmaversesdtm — release velocity, themes, recent moves, and the top alternatives to consider.
| Feature | Fulcrum | pharmaversesdtm |
|---|---|---|
| Sector | Analytics | Analytics |
| Velocity score | 6.3 | 0.0 |
| Sparks · 30d | 0 | 0 |
| Top themes | gis, esri-migration, offline-maps, field-data-capture | pharmaverse, sdtm, cdisc, test-data |
| Last editorial update | 4h ago | 5d ago |
| Website | — | Visit → |
Fulcrum is betting its whole map stack on Esri, with a hard Google Maps cutoff on September 1.
Fulcrum is a field data collection platform, and nearly every entry in the last month touches mapping. The web app ships weekly fix batches for layer rendering (KML/KMZ, MBTiles, ArcGIS Feature Services), while iOS and Android push near-weekly builds against the ArcGIS SDK. The newest iOS build turns to app-level responsiveness - database queries moved off the main path and the record editor kept interactive while Photo FastFill works in the background.
pharmaversesdtm is the test-data layer every pharmaverse package now builds against.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
Fulcrum is a field data collection platform, and nearly every entry in the last month touches mapping. The web app ships weekly fix batches for layer rendering (KML/KMZ, MBTiles, ArcGIS Feature Services), while iOS and Android push near-weekly builds against the ArcGIS SDK. The newest iOS build turns to app-level responsiveness - database queries moved off the main path and the record editor kept interactive while Photo FastFill works in the background.
The direction is a full consolidation onto Esri. The legacy Google Maps engine retires on September 1 with automatic migration for anyone who has not switched, and Esri now carries Google's satellite and street basemaps so the imagery argument is neutralized. Underneath, the mobile SDK moved to ArcGIS 300.0.0 and ONNX on-device inference gave way to a new INFERENCE format. Two capabilities are visibly staged behind early access rather than shipped: Photo FastFill, and a GPS integration still described as Alpha.
Expect the weeks before September 1 to stay dominated by migration-shaped fixes and Esri parity work, with Photo FastFill the nearer of the two early-access programs to general availability given it is already running in shipped builds.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
Two kinds of work alternate: adding domains and biomarkers for a new indication, and making the existing data easier to reach — CSV copies under inst/extdata for non-R programmers, a datasets preview vignette, reference pages categorised by therapeutic area, variable-by-variable breakdowns. Consistency fixes against CDISC terminology and SDTM guidelines run through every release.
New therapeutic areas will keep arriving in step with the admiral extension packages that need them; the neurology and metabolic datasets landed just ahead of admiralneuro and admiralmetabolic needing them, and lymphoma looks like the next in that sequence.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either Fulcrum or pharmaversesdtm.
dbt Fusion's second beta is adapter work: ClickHouse gets materializations, indexes, and catalogs
Holistics keeps fencing in the AI layer it spent the summer building.
Dovetail spent July opening doors to other tools and August making its own rooms easier to enter.
The 0.0.x train stops at CRAN: tulpa's engine ships to the ecosystem it already anchors.
AgencyAI got skills three weeks ago; everything since has been making them routine.
Interfaces gets the permissions layer it needed, one release after launching.
See all Fulcrum alternatives → · See all pharmaversesdtm alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. Fulcrum is currently shipping more aggressively (velocity 6.3 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Fulcrum is currently shipping more aggressively (velocity 6.3 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top Fulcrum alternatives in Analytics are ranked by recent ship velocity. Browse the "Fulcrum alternatives" section above for the current picks, or visit /alternatives/fulcrum for the full list with editorial commentary on each.
Top pharmaversesdtm alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaversesdtm alternatives" section above for the current picks, or visit /alternatives/pharmaversesdtm for the full list with editorial commentary on each.